Rosiglitazone in the Treatment of Type 2 Diabetes Mellitus: A Critical Review: by J. Malinowski and S. Bolesta, which appeared in the October 2000 issue, contained an error. Table VI indicates that pioglitazone treatment increases triglyceride levels by 9.0% to 9.6%, when in fact pioglitazone has been shown to decrease triglyceride levels by that percentage.

• Book ID: 117321083
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 20 KB
• Volume: 23
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/s0149-2918(01)80015-1